InvestorsHub Logo
Followers 91
Posts 28818
Boards Moderated 2
Alias Born 04/19/2013

Re: reaper247 post# 17984

Monday, 07/02/2018 7:40:02 AM

Monday, July 02, 2018 7:40:02 AM

Post# of 21373
That would be true except for the fact its 100% false

Instead of a $4.3 note, it is roughly a $5.5M note.



The existing Oncolix debt isnt roughly $5.5m. Further calculations & DD would provide anyone a better understanding

The current ONCX market cap is currently lower than the value of outstanding notes.



Using the search engine definition of marketcap is much different that what professional use, in other words, the experts. Determining market cap using only price & I&O is a great way of misinforming oneself of actual market value. As I pointed out, ignoring derivatives that convert into close to one billion shares would be a major misstep for any investor.

If convertible securities turn into common stock, this can change the number of issued and outstanding shares substantially. Fully diluted shares are important because they give investors and markets a better idea of a company's actual value.



I wouldn't paint a pretty picture to camouflage reality

If we have good news regarding the second cohort of Prolanta phase 1 FDA trials that could potentially spark a rally, those note holders wont be able to convert their preferred shares and dump into the rally.



LOL, Wonder what all those S-1 filings have been doing the past year? Oh right, registering all those shares for sale underlying the Notes. The preferred can convert whenever they chose next month as those shares have been fully paid for long ago

Hopefully investors seeking a clear understanding will take notice.




Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.